[Use of miramistin in the treatment of experimental suppurative wounds in states of impaired peripheral blood circulation].
Fesenko
V P
VP
Krivoshein
Iu S
IuS
Mogiliastyĭ
A A
AA
Pavlova
N V
NV
D000818:Animals; D000891:Anti-Infective Agents, Local / Q000008:administration & dosage / Q000627:therapeutic use*; D001548:Benzalkonium Compounds / Q000008:administration & dosage / Q000627:therapeutic use*; D007511:Ischemia / Q000503:physiopathology*; D008297:Male; D051381:Rats; D013492:Suppuration; D013997:Time Factors; D014945:Wound Healing; D014946:Wound Infection / Q000188:drug therapy* / Q000503:physiopathology
D000891:Anti-Infective Agents, Local; D001548:Benzalkonium Compounds; C058048:miramistin
Ispol'zovanie miramistina dlia lecheniia éksperimental'noĭ gnoīnoī rany v usloviiakh narushennogo perifericheskogo krovoobrashcheniia.